EPISODE · Mar 20, 2023 · 48 MIN
GA + MGD meet FDA
from Blink Collective · host James Deom OD & Roya Habibi OD
Do you struggle when training eye care professionals in your office? Need to know where to turn for help? Join this week's hosts, Jimmy and Roya, as they share tips on training their staff and the programs and training modules available. Hear about the recent FDA approval of Syfovre, the first treatment for geographic atrophy, a leading cause of blindness worldwide. In addition, they discuss the new and different treatment options for MGD. Have an idea for a topic you would like to hear more about, or would you like to nominate or be a guest on Try Not 2 Blink? We want to hear from you! Click here to send in a suggestion, or email us at [email protected] Training ProgramParaoptometric CertificationSyfovre is AMGDpprovedPipeline Treatment for GATP-03 for TarsusNOV03 for DED+MGDAZR-MD-001 for MGDTry Not to Blink Podcast is powered by Valley Contax
Embed this episode
What this episode covers
Do you struggle when training eye care professionals in your office? Need to know where to turn for help? Join this week's hosts, Jimmy and Roya, as they share tips on training their staff and the programs and training modules available. Hear about the recent FDA approval of Syfovre, the first treatment for geographic atrophy, a leading cause of blindness worldwide. In addition, they discuss the new and different treatment options for MGD. Have an idea for a topic you would like to hear m...
Ready to play
GA + MGD meet FDA
No transcript for this episode yet
Similar Episodes
No similar episodes found.